Who are Piperacillin/tazobactam or temocillin's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/piperacillin-tazobactam-or-temocillin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Piperacillin/tazobactam or temocillin — Competitive Intelligence Brief

Piperacillin/tazobactam or temocillin (Piperacillin/tazobactam or temocillin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Beta-lactam antibiotic / Beta-lactamase inhibitor combination (piperacillin/tazobactam); Beta-lactam antibiotic (temocillin). Area: Infec

phase 3 Beta-lactam antibiotic / Beta-lactamase inhibitor combination (piperacillin/tazobactam); Beta-lactam antibiotic (temocillin) Penicillin-binding proteins (PBPs); bacterial cell wall peptidoglycan Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Piperacillin/tazobactam or temocillin (Piperacillin/tazobactam or temocillin) — Assistance Publique - Hôpitaux de Paris. Piperacillin/tazobactam and temocillin are beta-lactam antibiotics that inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins, with tazobactam providing beta-lactamase inhibition to overcome resistance.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Piperacillin/tazobactam or temocillin TARGET	Piperacillin/tazobactam or temocillin	Assistance Publique - Hôpitaux de Paris	phase 3	Beta-lactam antibiotic / Beta-lactamase inhibitor combination (piperacillin/tazobactam); Beta-lactam antibiotic (temocillin)	Penicillin-binding proteins (PBPs); bacterial cell wall peptidoglycan

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Beta-lactam antibiotic / Beta-lactamase inhibitor combination (piperacillin/tazobactam); Beta-lactam antibiotic (temocillin) class)

Assistance Publique - Hôpitaux de Paris · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Piperacillin/tazobactam or temocillin — Competitive Intelligence Brief. https://druglandscape.com/ci/piperacillin-tazobactam-or-temocillin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab